Copyright Reports & Markets. All rights reserved.

Global Oncology Based Molecular Diagnostics Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Oncology Based Molecular Diagnostics Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Oncology Based Molecular Diagnostics Consumption 2014-2024
        • 2.1.2 Oncology Based Molecular Diagnostics Consumption CAGR by Region
      • 2.2 Oncology Based Molecular Diagnostics Segment by Type
        • 2.2.1 PCR
        • 2.2.2 Multiplex PCR
        • 2.2.3 In Situ Hybridization
        • 2.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
      • 2.3 Oncology Based Molecular Diagnostics Consumption by Type
        • 2.3.1 Global Oncology Based Molecular Diagnostics Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Oncology Based Molecular Diagnostics Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Oncology Based Molecular Diagnostics Sale Price by Type (2014-2019)
      • 2.4 Oncology Based Molecular Diagnostics Segment by Application
        • 2.4.1 Breast Cancer
        • 2.4.2 Prostate Cancer
        • 2.4.3 Colorectal Cancer
        • 2.4.4 Cervical Cancer
        • 2.4.5 Other
      • 2.5 Oncology Based Molecular Diagnostics Consumption by Application
        • 2.5.1 Global Oncology Based Molecular Diagnostics Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Oncology Based Molecular Diagnostics Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Oncology Based Molecular Diagnostics Sale Price by Application (2014-2019)

      3 Global Oncology Based Molecular Diagnostics by Players

      • 3.1 Global Oncology Based Molecular Diagnostics Sales Market Share by Players
        • 3.1.1 Global Oncology Based Molecular Diagnostics Sales by Players (2017-2019)
        • 3.1.2 Global Oncology Based Molecular Diagnostics Sales Market Share by Players (2017-2019)
      • 3.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Players
        • 3.2.1 Global Oncology Based Molecular Diagnostics Revenue by Players (2017-2019)
        • 3.2.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Players (2017-2019)
      • 3.3 Global Oncology Based Molecular Diagnostics Sale Price by Players
      • 3.4 Global Oncology Based Molecular Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Oncology Based Molecular Diagnostics Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Oncology Based Molecular Diagnostics Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Oncology Based Molecular Diagnostics by Regions

      • 4.1 Oncology Based Molecular Diagnostics by Regions
        • 4.1.1 Global Oncology Based Molecular Diagnostics Consumption by Regions
        • 4.1.2 Global Oncology Based Molecular Diagnostics Value by Regions
      • 4.2 Americas Oncology Based Molecular Diagnostics Consumption Growth
      • 4.3 APAC Oncology Based Molecular Diagnostics Consumption Growth
      • 4.4 Europe Oncology Based Molecular Diagnostics Consumption Growth
      • 4.5 Middle East & Africa Oncology Based Molecular Diagnostics Consumption Growth

      5 Americas

      • 5.1 Americas Oncology Based Molecular Diagnostics Consumption by Countries
        • 5.1.1 Americas Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
        • 5.1.2 Americas Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
      • 5.2 Americas Oncology Based Molecular Diagnostics Consumption by Type
      • 5.3 Americas Oncology Based Molecular Diagnostics Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Oncology Based Molecular Diagnostics Consumption by Countries
        • 6.1.1 APAC Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
        • 6.1.2 APAC Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
      • 6.2 APAC Oncology Based Molecular Diagnostics Consumption by Type
      • 6.3 APAC Oncology Based Molecular Diagnostics Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Oncology Based Molecular Diagnostics by Countries
        • 7.1.1 Europe Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
        • 7.1.2 Europe Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
      • 7.2 Europe Oncology Based Molecular Diagnostics Consumption by Type
      • 7.3 Europe Oncology Based Molecular Diagnostics Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Oncology Based Molecular Diagnostics by Countries
        • 8.1.1 Middle East & Africa Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Oncology Based Molecular Diagnostics Consumption by Type
      • 8.3 Middle East & Africa Oncology Based Molecular Diagnostics Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Oncology Based Molecular Diagnostics Distributors
      • 10.3 Oncology Based Molecular Diagnostics Customer

      11 Global Oncology Based Molecular Diagnostics Market Forecast

      • 11.1 Global Oncology Based Molecular Diagnostics Consumption Forecast (2019-2024)
      • 11.2 Global Oncology Based Molecular Diagnostics Forecast by Regions
        • 11.2.1 Global Oncology Based Molecular Diagnostics Forecast by Regions (2019-2024)
        • 11.2.2 Global Oncology Based Molecular Diagnostics Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Oncology Based Molecular Diagnostics Forecast by Type
      • 11.8 Global Oncology Based Molecular Diagnostics Forecast by Application

      12 Key Players Analysis

      • 12.1 Abbott Laboratories
        • 12.1.1 Company Details
        • 12.1.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Abbott Laboratories News
      • 12.2 Bayer Healthcare
        • 12.2.1 Company Details
        • 12.2.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Bayer Healthcare News
      • 12.3 Becton Dickinson
        • 12.3.1 Company Details
        • 12.3.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Becton Dickinson News
      • 12.4 Cepheid
        • 12.4.1 Company Details
        • 12.4.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Cepheid News
      • 12.5 Dako
        • 12.5.1 Company Details
        • 12.5.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.5.3 Dako Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Dako News
      • 12.6 Danaher Corporation
        • 12.6.1 Company Details
        • 12.6.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Danaher Corporation News
      • 12.7 Gen Probe(Hologic)
        • 12.7.1 Company Details
        • 12.7.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Gen Probe(Hologic) News
      • 12.8 Roche Diagnostics
        • 12.8.1 Company Details
        • 12.8.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Roche Diagnostics News
      • 12.9 Siemens Healthcare
        • 12.9.1 Company Details
        • 12.9.2 Oncology Based Molecular Diagnostics Product Offered
        • 12.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Siemens Healthcare News

      13 Research Findings and Conclusion

      Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor.

      According to this study, over the next five years the Oncology Based Molecular Diagnostics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oncology Based Molecular Diagnostics business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Based Molecular Diagnostics market by product type, application, key manufacturers and key regions and countries.

      This study considers the Oncology Based Molecular Diagnostics value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      PCR
      Multiplex PCR
      In Situ Hybridization
      Isothermal Nucleic Acid Amplification Technology (INAAT)
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Breast Cancer
      Prostate Cancer
      Colorectal Cancer
      Cervical Cancer
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Abbott Laboratories
      Bayer Healthcare
      Becton Dickinson
      Cepheid
      Dako
      Danaher Corporation
      Gen Probe(Hologic)
      Roche Diagnostics
      Siemens Healthcare

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Oncology Based Molecular Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Oncology Based Molecular Diagnostics market by identifying its various subsegments.
      Focuses on the key global Oncology Based Molecular Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Oncology Based Molecular Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Oncology Based Molecular Diagnostics submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now